Voloridge Investment Management
CVS icon

Voloridge Investment Management’s CVS Health CVS Stock Holding History

Voloridge Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-903,736
Closed -$40.6M – 1206
2024
Q4 		$40.6M Sell
903,736
-1,032,197
-53% -$57.9M 0.14% 199
2024
Q3 		$122M Buy
1,935,933
+411,760
+27% +$24M 0.44% 33
2024
Q2 		$90M Buy
1,524,173
+896,426
+143% +$56.1M 0.33% 65
2024
Q1 		$50.1M Buy
627,747
+240,096
+62% +$18.3M 0.18% 159
2023
Q4 		$30.6M Sell
387,651
-1,230,540
-76% -$87.6M 0.12% 220
2023
Q3 		$113M Sell
1,618,191
-1,093,425
-40% -$77.5M 0.56% 22
2023
Q2 		$187M Buy
2,711,616
+194,114
+8% +$13.8M 0.88% 6
2023
Q1 		$187M Buy
2,517,502
+2,430,762
+2,802% +$204M 0.93% 5
2022
Q4 		$8.08M Sell
86,740
-231,124
-73% -$22.3M 0.05% 495
2022
Q3 		$30.3M Sell
317,864
-662,882
-68% -$65.6M 0.16% 176
2022
Q2 		$90.9M Buy
980,746
+912,004
+1,327% +$89M 0.47% 25
2022
Q1 		$6.96M Buy
+68,742
New +$7.22M 0.04% 524
2021
Q3 		– Sell
-662,734
Closed -$55.3M – 1684
2021
Q2 		$55.3M Buy
662,734
+518,745
+360% +$42.5M 0.38% 33
2021
Q1 		$10.8M Buy
+143,989
New +$10.5M 0.08% 331
2020
Q2 		– Sell
-302,295
Closed -$17.9M – 1297
2020
Q1 		$17.9M Buy
302,295
+129,069
+75% +$8.62M 0.52% 33
2019
Q4 		$12.9M Buy
+173,226
New +$12.2M 0.25% 92
2019
Q3 		– Sell
-284,147
Closed -$15.5M – 1085
2019
Q2 		$15.5M Buy
+284,147
New +$15.3M 0.43% 42
2017
Q2 		– Sell
-739,636
Closed -$58.1M – 438
2017
Q1 		$58.1M Buy
+739,636
New +$59M 1.41% 11
2016
Q4 		– Sell
-141,837
Closed -$12.6M – 627
2016
Q3 		$12.6M Sell
141,837
-410,624
-74% -$38.8M 0.27% 59
2016
Q2 		$52.9M Buy
+552,461
New +$55.1M 1.51% 15
2015
Q4 		– Sell
-107,729
Closed -$10.4M – 208
2015
Q3 		$10.4M Sell
107,729
-353,227
-77% -$37.1M 0.49% 52
2015
Q2 		$48.3M Buy
460,956
+360,262
+358% +$36.8M 2.46% 6
2015
Q1 		$10.4M Buy
+100,694
New +$10.2M 0.5% 57

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Voloridge Investment Management's CVS Position: Q1 2025 in Review

Voloridge Investment Management sold out of CVS Health (CVS) in Q1 2025, closing a stake of 903,736 shares — an estimated $40.6M sold.

Voloridge Investment Management first reported a position in CVS in Q1 2015 and held it in 23 quarters. The position peaked at $187M in Q2 2023. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Voloridge Investment Management reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 903,736 CVS Health shares in Q1 2025, an estimated $40.6M.
  • Voloridge Investment Management first reported a position in CVS Health in Q1 2015 and held it in 23 quarters.
  • Voloridge Investment Management's CVS Health position peaked at $187M in Q2 2023.
  • 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.